<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sister chromatid exchanges (SCEs), a sensitive measure of chromosome damage, were counted in peripheral-blood lymphocytes from 10 patients with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e> receiving <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had abnormal counts </plain></SENT>
<SENT sid="2" pm="."><plain>Damage was related to both daily dose and duration of therapy and was occurring at a greater rate than its repair </plain></SENT>
<SENT sid="3" pm="."><plain>The patient who had been treated the longest and had received the highest total dose also had the highest SCE count </plain></SENT>
<SENT sid="4" pm="."><plain>He died from <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>SCE analysis may provide a method for detecting patients at risk from oncogenic effects of cytotoxic drugs </plain></SENT>
</text></document>